危重患儿血培养诊断管理协作与培养率、抗生素使用及患者结局的关联
Bright STAR协作覆盖美国14个PICU,2017至2020年实施以血培养实践为重点的本地质量改进项目。项目实施后血培养率相对下降33%,广谱抗生素使用和启动率分别相对下降13%和8%,CLABSI相对下降36%,死亡率、住院时长、再入院及脓毒症发生率无显著变化。
要点
- 多学科诊断管理可安全降低PICU血培养率33%。
- 广谱抗生素使用日相对下降13%,启动率相对下降8%。
- CLABSI率相对下降36%,安全指标无恶化。
核心结论
- 多学科诊断管理干预可减少PICU血培养和抗生素使用,且死亡率、住院时长、再入院及脓毒症发生率无显著变化。
研究设计与样本
- 前瞻性质量改进协作研究,纳入美国14个PICU,时间为2017至2020年,数据来自各PICU及儿童医院协会儿科健康信息系统。
主要发现
- 血培养率从实施前149.4/1000患者日/月降至实施后100.5/1000患者日/月,相对降低33%(95%CI 26%-39%)。
- 广谱抗生素使用从506天降至440天/1000患者日/月,相对降低13%(95%CI 7%-19%)。
- 广谱抗生素启动率从58.1降至53.6次/1000患者日/月,相对降低8%(95%CI 4%-11%)。
- CLABSI率从1.8降至1.1/1000中心静脉导管日/月,相对降低36%(95%CI 20%-49%)。
- 死亡率、住院时长、再入院、脓毒症及严重脓毒症/脓毒性休克发生率在实施前后相似。
临床怎么用
- 在PICU推行聚焦血培养实践的多学科诊断管理项目,可降低血培养和广谱抗生素使用,同时监测安全与平衡指标。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Blood culture overuse in the pediatric intensive care unit (PICU) can lead to unnecessary antibiotic use and contribute to antibiotic resistance. Optimizing blood culture practices through diagnostic stewardship may reduce unnecessary blood cultures and antibiotics. OBJECTIVE: To evaluate the association of a 14-site multidisciplinary PICU blood culture collaborative with culture rates, antibiotic use, and patient outcomes. DESIGN, SETTING, AND PARTICIPANTS: This prospective quality improvement (QI) collaborative involved 14 PICUs across the United States from 2017 to 2020 for the Bright STAR (Testing Stewardship for Antibiotic Reduction) collaborative. Data were collected from each participating PICU and from the Children's Hospital Association Pediatric Health Information System for prespecified primary and secondary outcomes. EXPOSURES: A local QI program focusing on blood culture practices in the PICU (facilitated by a larger QI collaborative). MAIN OUTCOMES AND MEASURES: The primary outcome was blood culture rates (per 1000 patient-days/mo). Secondary outcomes included broad-spectrum antibiotic use (total days of therapy and new initiations of broad-spectrum antibiotics ≥3 days after PICU admission) and PICU rates of central line-associated bloodstream infection (CLABSI), Clostridioides difficile infection, mortality, readmission, length of stay, sepsis, and severe sepsis/septic shock. RESULTS: Across the 14 PICUs, the blood culture rate was 149.4 per 1000 patient-days/mo preimplementation and 100.5 per 1000 patient-days/mo postimplementation, for a 33% relative reduction (95% CI, 26%-39%). Comparing the periods before and after implementation, the rate of broad-spectrum antibiotic use decreased from 506 days to 440 days per 1000 patient-days/mo, respectively, a 13% relative reduction (95% CI, 7%-19%). The broad-spectrum antibiotic initiation rate decreased from 58.1 to 53.6 initiations/1000 patient-days/mo, an 8% relative reduction (95% CI, 4%-11%). Rates of CLABSI decreased from 1.8 to 1.1 per 1000 central venous line days/mo, a 36% relative reduction (95% CI, 20%-49%). Mortality, length of stay, readmission, sepsis, and severe sepsis/septic shock were similar before and after implementation. CONCLUSIONS AND RELEVANCE: Multidisciplinary diagnostic stewardship interventions can reduce blood culture and antibiotic use in the PICU. Future work will determine optimal strategies for wider-scale dissemination of diagnostic stewardship in this setting while monitoring patient safety and balancing measures.
引用
- Woods-Hill CZ, Colantuoni EA, Koontz DW, et al. Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative. JAMA Pediatr. 2022. PMID: 35499841. doi:10.1001/jamapediatrics.2022.1024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。